The FDA has given AliveCor 510(k) clearance to market an algorithm that can accurately identify the presence of atrial fibrillation using the company's smartphone-based ECG. The technology allows patients to take ECG readings using their Android or Apple mobile devices, and send the information to a cardiologist to confirm whether they have atrial fibrillation.
A-fib algorithm used with AliveCor's smartphone ECG wins FDA nod
SmartBrief Job Listings for Health Care
|Compliance and Ethics Director||
Sysmex America, Inc.
|Director, Site Quality Management||
|Palm Springs, CA|
|Compliance Officer-Medical Products||
W. L. Gore